These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 7514400)

  • 41. Specific probe selection from landscape phage display library and its application in enzyme-linked immunosorbent assay of free prostate-specific antigen.
    Lang Q; Wang F; Yin L; Liu M; Petrenko VA; Liu A
    Anal Chem; 2014 Mar; 86(5):2767-74. PubMed ID: 24533565
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Display of biologically active proteins on the surface of filamentous phages: a cDNA cloning system for selection of functional gene products linked to the genetic information responsible for their production.
    Crameri R; Suter M
    Gene; 1993 Dec; 137(1):69-75. PubMed ID: 8282202
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Introduction to vectors derived from filamentous phages.
    Greenstein D; Brent R
    Curr Protoc Mol Biol; 2001 May; Chapter 1():Unit1.14. PubMed ID: 18265042
    [TBL] [Abstract][Full Text] [Related]  

  • 44. New vectors for peptide display on the surface of filamentous bacteriophage.
    Malik P; Perham RN
    Gene; 1996 May; 171(1):49-51. PubMed ID: 8675029
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Co-selection of cognate antibody-antigen pairs by selectively-infective phages.
    Krebber C; Spada S; Desplancq D; Plückthun A
    FEBS Lett; 1995 Dec; 377(2):227-31. PubMed ID: 8543056
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Proteolytic selection for protein folding using filamentous bacteriophages.
    Kristensen P; Winter G
    Fold Des; 1998; 3(5):321-8. PubMed ID: 9806934
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Extending filamentous phage host range by the grafting of a heterologous receptor binding domain.
    Marzari R; Sblattero D; Righi M; Bradbury A
    Gene; 1997 Jan; 185(1):27-33. PubMed ID: 9034309
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A comprehensive analysis of filamentous phage display vectors for cytoplasmic proteins: an analysis with different fluorescent proteins.
    Velappan N; Fisher HE; Pesavento E; Chasteen L; D'Angelo S; Kiss C; Longmire M; Pavlik P; Bradbury AR
    Nucleic Acids Res; 2010 Mar; 38(4):e22. PubMed ID: 19955231
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Targeted filamentous bacteriophages as therapeutic agents.
    Yacoby I; Benhar I
    Expert Opin Drug Deliv; 2008 Mar; 5(3):321-9. PubMed ID: 18318653
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Screening for PreS specific binding ligands with a phage displayed peptides library.
    Deng Q; Zhuang M; Kong YY; Xie YH; Wang Y
    World J Gastroenterol; 2005 Jul; 11(26):4018-23. PubMed ID: 15996026
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vivo versus in vitro screening or selection for catalytic activity in enzymes and abzymes.
    Fastrez J
    Mol Biotechnol; 1997 Feb; 7(1):37-55. PubMed ID: 9163721
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular cloning and expression of an alternative hKLK3 transcript coding for a variant protein of prostate-specific antigen.
    Heuzé N; Olayat S; Gutman N; Zani ML; Courty Y
    Cancer Res; 1999 Jun; 59(12):2820-4. PubMed ID: 10383139
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of prostate specific antigen on the surface of a filamentous phage.
    Eerola R; Saviranta P; Lilja H; Pettersson K; Lövgren T; Karp M
    Biochem Biophys Res Commun; 1994 May; 200(3):1346-52. PubMed ID: 7514400
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of monoclonal antibodies against prostate specific antigen produced by genetic immunization.
    Leinonen J; Niemelä P; Lövgren J; Bocchi L; Pettersson K; Nevanlinna H; Stenman UH
    J Immunol Methods; 2004 Jun; 289(1-2):157-67. PubMed ID: 15251421
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hormone phage: an enrichment method for variant proteins with altered binding properties.
    Bass S; Greene R; Wells JA
    Proteins; 1990; 8(4):309-14. PubMed ID: 1708882
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of prostate-specific antigen binding peptides selected by phage display technology.
    Ferrieu-Weisbuch C; Michel S; Collomb-Clerc E; Pothion C; Deléage G; Jolivet-Reynaud C
    J Mol Recognit; 2006; 19(1):10-20. PubMed ID: 16312021
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.